Delta9-tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature

Clinical Pharmacology and Therapeutics

Volumn 97, Issue 6, 2015, Pages 587-596

  Fowler, C J ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CANNABIDIOL; CANNABINOID RECEPTOR; DRONABINOL;

ARTICLE; CANCER CHEMOTHERAPY; CELL INVASION; CELL MOTILITY; CELL VIABILITY; GLEASON SCORE; HUMAN; IN VITRO STUDY; NEOPLASM; PRIORITY JOURNAL; PROTEIN EXPRESSION; CELL SURVIVAL; DRUG EFFECTS; NEOPLASMS; PATHOLOGY; PHYSIOLOGY;

CANNABIDIOL; CELL SURVIVAL; DRONABINOL; HUMANS; NEOPLASMS; RECEPTORS, CANNABINOID;

EID: 84938932680     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1002/cpt.84     Document Type: Article

References (76)

1. Munson, A.E., Harris, L.S., Friedman, M.A., Dewey, W.L., & Carchman, R.A. Antineoplastic activity of cannabinoids. J. Natl. Cancer Inst. 55, 597-602 (1975
2. Galve-Roperh, I., Sánchez, C., Cortés, M., Gómez del Pulgar, T., Izquierdo, M., & Guzmán, M. Anti-Tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat. Med. 6, 313-319 (2000
3. Guzmán, M., et al. A pilot clinical study of D9-Tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br. J. Cancer 95, 197-203 (2006
4. Nithipatikom, K., et al. 2-Arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion. Cancer Res. 64, 8826-8830 (2004
5. Carracedo, A., et al. Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes. Cancer Res. 66, 6748-6755 (2006
6. Sánchez, M.G., Ruiz-Llorente, L., Sánchez, A.M., & Díaz-Laviada, I. Activation of phosphoinositide 3-kinase/PKB pathway by CB(1) and CB(2) cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction. Cell Signal. 15, 851-859 (2003
7. Lorente, M., et al. Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action. Cell Death Differ. 18, 959-973 (2011
8. Richardson, S.J., Widmer, M., Zajicek, J., & Rule, S.A. Physiological doses of cannabinoids do not adversely affect MCL viability. Leuk. Lymphoma 48, 1855-1857 (2007
9. McKallip, R.J., Nagarkatti, M., & Nagarkatti, P.S. D-9-Tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response. J. Immunol. 174, 3281-3289 (2005
10. Cipriano, M., Gouveia-Figueira, S., Persson, E., Nording, M., & Fowler, C.J. The influence of monoacylglycerol lipase inhibition upon the expression of epidermal growth factor receptor in human PC-3 prostate cancer cells. BMC Res. Notes 7, 441 (2014
11. Flygare, J., & Sander, B. The endocannabinoid system in cancer-potential therapeutic target?. Semin. Cancer Biol. 18, 176-189 (2008
12. Freimuth, N., Ramer, R., & Hinz, B. Antitumorigenic effects of cannabinoids beyond apoptosis. J. Pharmacol. Exp. Ther. 332, 336-344 (2010
13. Guindon, J., & Hohmann, A.G. The endocannabinoid system and cancer: therapeutic implication. Br. J. Pharmacol. 163, 1447-1463 (2011
14. Singh, Y., & Bali, C. Cannabis extract treatment for terminal acute lymphoblastic leukemia with a Philadelphia chromosome mutation. Case Rep. Oncol. 6, 585-592 (2013
15. Endsley, M.P., et al. Expression and function of fatty acid amide hydrolase in prostate cancer. Int. J. Cancer 123, 1318-1326 (2008
16. Nomura, D.K., Long, J.Z., Niessen, S., Hoover, H.S., Ng, S.W., & Cravatt, B.F. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell 140, 49-61 (2010
17. Nomura, D.K., et al. Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer. Chem. Biol. 18, 846-856 (2011
18. Kola, I., & Landis, J. Can the pharmaceutical industry reduce attrition rates?. Nat. Rev. Drug Discov. 3, 711-715 (2004
19. Massi, P., Solinas, M., Cinquina, V., & Parolaro, D. Cannabidiol as potential anticancer drug. Br. J. Clin. Pharmacol. 75, 303-312 (2013
20. McPartland, J.M., Glass, M., & Pertwee, R.G. Meta-Analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences. Br. J. Pharmacol. 152, 583-593 (2007
21. Huestis, M.A. Human cannabinoid pharmacokinetics. Chem. Biodivers. 4, 1770-1804 (2007
22. Nadulski, T., et al. Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of D9-Tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract. Ther. Drug Monit. 27, 799-810 (2005
23. Jacobsson, S.O.P., Rongård, E., Stridh, M., Tiger, G., & Fowler, C.J. Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability. Biochem. Pharmacol. 60, 1807-1813 (2000
24. De Petrocellis, L., et al. Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-Apoptotic effects and underlying mechanisms. Br. J. Pharmacol. 168, 79-102 (2013
25. McAllister, S.D., et al. Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells. J. Neurooncol. 74, 31-40 (2005
26. Carrier, E.J., Auchampach, J.A., & Hillard, C.J. Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression. Proc. Natl. Acad. Sci. USA 103, 7895-7900 (2006
27. De Petrocellis, L., et al. Effects of cannabinoids and cannabinoidenriched cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br. J. Pharmacol. 163, 1479-1494 (2011
28. Ramer, R., et al. Cannabidiol Inhibits Lung Cancer Cell Invasion and Metastasis Via Intercellular Adhesion molecule-1. FASEB J. 26, 1535-1548 (2012
29. McAllister, S.D., Christian, R.T., Horowitz, M.P., Garcia, A., & Desprez, P.Y. Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells. Mol. Cancer Ther. 6, 2921-2927 (2007
30. Hampson, A.J., Grimaldi, M., Axelrod, J., & Wink, D. Cannabidiol and (-)D9-Tetrahydrocannabinol are neuroprotective antioxidants. Proc. Natl. Acad. Sci. USA 95, 8268-8273 (1998
31. Rimmerman, N., et al. Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death. Cell Death Dis., 4, e949 (2013
32. Macpherson, T., Armstrong, J.A., Criddle, D.N., & Wright, K.L. Physiological intestinal oxygen modulates the Caco-2 cell model and increases sensitivity to the phytocannabinoid cannabidiol. In Vitro Cell Dev. Biol. Anim. 50, 417-426 (2014
33. Zhu, H.J., et al. Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana. J. Pharmacol. Exp. Ther. 317, 850-857 (2006
34. Holland, M.L., Lau, D.T., Allen, J.D., & Arnold, J.C. The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids. Br. J. Pharmacol. 152, 815-824 (2007
35. Holland, M.L., Allen, J.D., & Arnold, J.C. Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1). Eur. J. Pharmacol. 591, 128-131 (2008
36. White, H.L., & Tansik, R.L. Effects of D9-Tetrahydrocannabinol and cannabidiol on phospholipase and other enzymes regulating arachidonate metabolism. Prostaglandins Med. 4, 409-417 (1980
37. Wheal, A.J., Cipriano, M., Fowler, C.J., Randall, M.D., & O?Sullivan, S.E. Cannabidiol improves vasorelaxation in Zucker diabetic fatty rats through cyclooxygenase activation. J. Pharmacol. Exp. Ther. 351, 457-466 (2014
38. Purohit, V., Ahluwahlia, B.S., & Vigersky, R.A. Marihuana inhibits dihydrotestosterone binding to the androgen receptor. Endocrinology 107, 848-850 (1980
39. Baell, J., & Walters, M.A. Chemistry: chemical con artists foil drug discovery. Nature 513, 481-483 (2014
40. Ingólfsson, H.I., et al. Phytochemicals perturb membranes and promiscuously alter protein function. ACS Chem. Biol. 9, 1788-1798 (2014
41. Thors, L., Alajakku, K., & Fowler, C.J. The specific tyrosine kinase inhibitor genistein inhibits the enzymic hydrolysis of anandamide: implications for anandamide uptake. Br. J. Pharmacol. 150, 951-960 (2007
42. Crespillo, A., et al. Reduction of body weight, liver steatosis and expression of stearoyl-CoA desaturase 1 by the isoflavone daidzein in diet-induced obesity. Br. J. Pharmacol. 164, 1899-1915 (2011
43. Caffarel, M.M., et al. Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition. Mol. Cancer 9, 196 (2010
44. Hart, S., Fischer, O.M., & Ullrich, A. Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor. Cancer Res. 64, 1943-1950 (2004
45. Sánchez, M.G., Sánchez, A.M., Ruiz-Llorente, L., & Díaz-Laviada, I. Enhancement of androgen receptor expression induced by (R)-methanandamide in prostate LNCaP cells. FEBS Lett. 555, 561-566 (2003
46. Torres, S., et al. A combined preclinical therapy of cannabinoids and temozolomide against glioma. Mol. Cancer Ther. 10, 90-103 (2011
47. Adams, D.J. The Valley of Death in anticancer drug development: a reassessment. Trends Pharmacol. Sci. 33, 173-180 (2012
48. Solinas, M., et al. Cannabidiol, a non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitarget effect. PLoS One 8, e76918 (2013
49. Bisogno, T., et al. Analysis of endocannabinoid system in a 3D cellon-chip model of human tumors. The 24th Annual International Cannabinoid Research Society Symposium on the Cannabinoids, Baveno, Italy, 28 June-3 July 2014
50. Ramer, R., et al. COX-2 and PPAR-g confer cannabidiol-induced apoptosis of human lung cancer cells. Mol. Cancer Ther. 12, 69-82 (2013
51. Romano, B., Borrelli, F., Pagano, E., Cascio, M.G., Pertwee, R.G., & Izzo, A.A. Inhibition of colon carcinogenesis by a standardized cannabis sativa extract with high content of cannabidiol. Phytomedicine 21, 631-639 (2014
52. Zhu, L.X., et al. D-9-Tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J. Immunol. 165, 373-380 (2000
53. Lorente, M., et al. Amphiregulin is a factor for resistance of glioma cells to cannabinoid-induced apoptosis. Glia. 57, 1374-1385 (2009
54. Hernán Pérez de la Ossa, D., et al. Local delivery of cannabinoidloaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme. PLoS One 8, e54795 (2013
55. Johnson, J.I., et al. Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. Br. J. Cancer 84, 1424-1431 (2001
56. McAllister, S.D., et al. Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis. Breast Cancer Res. Treat. 129, 37-47 (2011
57. Murase, R., et al. Targeting multiple cannabinoid anti-Tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer. Br. J. Pharmacol. 171, 4464-4477 (2014
58. Aviello, G., et al. Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer. J. Mol. Med. (Berl). 90, 925-934 (2012
59. Chan, P.C., Sills, R.C., Braun, A.G., Haseman, J.K., & Bucher, J.R. Toxicity and carcinogenicity of D 9-Tetrahydrocannabinol in Fischer rats and B6C3F1 mice. Fund. Appl. Toxicol. 30, 109-117 (1996
60. Stout, S.M., & Cimino, N.M. Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review. Drug Metab. Rev. 46, 86-95 (2014
61. Scott, K.A., Dalgleish, A.G., & Liu, W.M. The combination of cannabidiol and D9-Tetrahydrocanabinol enhances the anticancer effects of radiation in an orthotopic murine glioma model. Mol. Cancer Ther. 13, 2955-2967 (2014
62. Larrinaga, G., et al. Cannabinoid CB1 receptor is downregulated in clear cell renal cell carcinoma. J. Histochem. Cytochem. 58, 1129-1134 (2010
63. Michalski, C.W., et al. Cannabinoids in pancreatic cancer: correlation with survival and pain. Int. J. Cancer 122, 742-750 (2008
64. Chung, S.C., et al. A high cannabinoid CB(1) receptor immunoreactivity is associated with disease severity and outcome in prostate cancer. Eur. J. Cancer 45, 174-182 (2009
65. Klein Nulent, T.J.W., et al. Cannabinoid receptor-2 immunoreactivity is associated with survival in squamous cell carcinoma of the head and neck. Br. J. Oral Maxillofac. Surg. 51, 604-609 (2013
66. Xu, X., et al. Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma. Cancer Genet. Cytogenet. 171, 31-38 (2006
67. Jia, N., et al. Cannabinoid CB2 receptor as a new phototherapy target for the inhibition of tumor growth. Mol. Pharm. 11, 1919-1929 (2014
68. Cudaback, E., Marrs, W., Moeller, T., & Stella, N. The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas. PLoS One 5, e8702 (2010
69. Cipriano, M., Haggstrom, J., Hammarsten, P., & Fowler, C.J. Association between cannabinoid CB1 receptor expression and Akt signalling in prostate cancer. PLoS One 8, e65798 (2013
70. Haggstrom, J., et al. Potential upstream regulators of cannabinoid receptor 1 signaling in prostate cancer: a Bayesian network analysis of data from a tissue microarray. Prostate 74, 1107-1117 (2014
71. Ramer, R., & Hinz, B. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1. J. Natl. Cancer Inst. 100, 59-69 (2008
72. Ramer, R., & Hinz, B. Cyclooxygenase-2 and tissue inhibitor of matrix metalloproteinases-1 confer the antimigratory effect of cannabinoids on human trabecular meshwork cells. Biochem. Pharmacol. 80, 846-857 (2010
73. Ramer, R., Rohde, A., Merkord, J., Rohde, H., & Hinz, B. Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of cannabidiol on human lung cancer cells. Pharm. Res. 27, 2162-2174 (2010
74. Marcu, J.P., et al. Cannabidiol enhances the inhibitory effects of D9-Tetrahydrocannabinol on human glioblastoma cell proliferation and survival. Mol. Cancer Ther. 9, 180-189 (2010
75. Maor, Y., Yu, J., Kuzontkoski, P.M., Dezube, B.J., Zhang, X., & Groopman, J.E. Cannabidiol inhibits growth and induces programmed cell death in kaposi sarcoma-Associated herpesvirus-infected endothelium. Genes Cancer 3, 512-520 (2012
76. Morelli, M.B., et al. The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2. Int. J. Cancer 134, 2534-2546 (2014